scholarly journals Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study

BMJ ◽  
2014 ◽  
Vol 349 (sep12 1) ◽  
pp. g5410-g5410 ◽  
Author(s):  
N. A. de Glas ◽  
A. J. M. de Craen ◽  
E. Bastiaannet ◽  
E. G. Op 't Land ◽  
M. Kiderlen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Screening ◽  
The Netherlands ◽  
Older Women ◽  
Breast Cancer Screening ◽  
Screening Programme ◽  
Population Based ◽  
Population Based Study ◽  
Breast Cancer Screening Programme ◽  
Cancer Screening Programme

scholarly journals Lower attendance rates in immigrant versus non-immigrant women in the Norwegian Breast Cancer Screening Programme

2017 ◽  
Vol 25 (3) ◽  
pp. 155-161 ◽  
Author(s):  
Sameer Bhargava ◽  
Kaitlyn Tsuruda ◽  
Kåre Moen ◽  
Ida Bukholm ◽  
Solveig Hofvind
Keyword(s):  
Breast Cancer ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Screening Programme ◽  
Immigrant Women ◽  
Population Based ◽  
Mammographic Screening ◽  
Attendance Rates ◽  
Breast Cancer Screening Programme ◽  
Cancer Screening Programme

Objective The Norwegian Breast Cancer Screening Programme invites women aged 50–69 to biennial mammographic screening. Although 84% of invited women have attended at least once, attendance rates vary across the country. We investigated attendance rates among various immigrant groups compared with non-immigrants in the programme. Methods There were 4,053,691 invitations sent to 885,979 women between 1996 and 2015. Using individual level population-based data from the Cancer Registry and Statistics Norway, we examined percent attendance and calculated incidence rate ratios, comparing immigrants with non-immigrants, using Poisson regression, following women's first invitation to the programme and for ever having attended. Results Immigrant women had lower attendance rates than the rest of the population, both following the first invitation (53.1% versus 76.1%) and for ever having attended (66.9% versus 86.4%). Differences in attendance rates between non-immigrant and immigrant women were less pronounced, but still present, when adjusted for sociodemographic factors. We also identified differences in attendance between immigrant groups. Attendance increased with duration of residency in Norway. A subgroup analysis of migrants' daughters showed that 70.0% attended following the first invitation, while 82.3% had ever attended. Conclusions Immigrant women had lower breast cancer screening attendance rates. The rationale for immigrant women's non-attendance needs to be explored through further studies targeting women from various birth countries and regions.

Nationwide breast cancer screening programme fully implemented in the Netherlands

The Breast ◽  
2001 ◽  
Vol 10 (1) ◽  
pp. 6-11 ◽  
Author(s):  
J. Fracheboud ◽  
H.J. de Koning ◽  
R. Boer ◽  
J.H. Groenewoud ◽  
A.L.M. Verbeek ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Screening ◽  
The Netherlands ◽  
Breast Cancer Screening ◽  
Screening Programme ◽  
Breast Cancer Screening Programme ◽  
Cancer Screening Programme

scholarly journals Quality assured implementation of the Slovenian breast cancer screening programme

PLoS ONE ◽  
2021 ◽  
Vol 16 (10) ◽  
pp. e0258343
Author(s):  
Katja Jarm ◽  
Maksimiljan Kadivec ◽  
Cveto Šval ◽  
Kristijana Hertl ◽  
Maja Primic Žakelj ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Quality Assurance ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Screening Programme ◽  
Population Based ◽  
Professional Staff ◽  
Successful Implementation ◽  
Breast Cancer Screening Programme ◽  
Cancer Screening Programme

Setting The organised, population-based breast cancer screening programme in Slovenia began providing biennial mammography screening for women aged 50–69 in 2008. The programme has taken a comprehensive approach to quality assurance as recommended by the European guidelines for quality assurance in breast cancer screening and diagnosis (4th edition), including centralized assessment, training and supervision, and proactive monitoring of performance indicators. This report describes the progress of implementation and rollout from 2003 through 2019. Methods The screening protocol and key quality assurance procedures initiated during the planning from 2003 and rollout from 2008 of the screening programme, including training of the professional staff, are described. The organisational structure, gradual geographical rollout, and coverage by invitation and examination are presented. Results The nationwide programme was up and running in all screening regions by the end of 2017, at which time the nationwide coverage by invitation and examination had reached 70% and 50%, respectively. Nationwide rollout of the population-based programme was complete by the end of 2019. By this time, coverage by invitation and examination had reached 98% and 76%, respectively. The participation rates consistently exceeded 70% from 2014 to 2019. Conclusions The successful implementation of the screening programme can be attributed to an independent central management, external guidance, and strict adherence to quality assurance procedures, all of which contributed to increasing governmental and popular support. The benefits of quality assurance have influenced all aspects of breast care and have provided a successful model for multidisciplinary management of other diseases.

Rising incidence of breast cancer after completion of the first prevalent round of the breast cancer screening programme

2002 ◽  
Vol 9 (3) ◽  
pp. 120-124 ◽  
Author(s):  
L.J. Schouten ◽  
J.M. de Rijke ◽  
J.A.M. Huveneers ◽  
A.L.M. Verbeek
Keyword(s):  
Breast Cancer ◽  
Cancer Screening ◽  
The Netherlands ◽  
Breast Cancer Screening ◽  
Screening Programme ◽  
Detection Rates ◽  
Node Positive ◽  
Breast Cancer Screening Programme ◽  
Cancer Screening Programme ◽  
Prevalent Screening

OBJECTIVES: After completion of the prevalent screening round of the breast cancer screening programme in Limburg, The Netherlands, incidences started rising once again. This increase was contrary to expectations, which had predicted a slightly higher, but stable, incidence after the first screening round. The trends in incidence were studied to find explanations for the observed rise in incidence. SETTING: Breast cancer screening programme in mid-Limburg and southern Limburg, the Netherlands. METHODS: The data files of the breast cancer screening programme and the Maastricht cancer registry were linked to evaluate the effect of breast cancer screening. Only the first primary breast tumour was included in the evaluation. RESULTS: The second peak of incidence after the prevalent screening round was 45% higher than the incidences before the start of the screening. Also, the decrease in incidence of large and node positive tumours was interrupted. Compared with national detection rates, the number of screen detected cancers was lower before 1995 and higher after that year. After 1997, incidence decreased again of all breast cancers, but also of large and node positive tumours. The incidence of node positive tumours showed large fluctuations, probably due to the introduction of the sentinel node procedure and immunohistochemistry. In 1999, incidence of large tumours and node positive tumours was 18% and 28%, respectively, lower than before the start of the screening. CONCLUSIONS: An increase in the background incidences and improved detection in the screening programme most likely explain this trend. The improved detection after 1995, and the lower than desirable decrease in large tumours, indicate that the screening performance was not optimal before 1996. The incidence of node positive tumours cannot be used any more as an indicator of the success of the screening programme because of detection bias.

Sign in / Sign up

Export Citation Format

Share Document